AbbVie Inc. against AstraZeneca PLC — live side-by-side technical comparison.
Prices as of 2026-11-10T21:02:16+00:00 UTC · updates daily
ABBV leads 5 of the 6 windows we measure — over 1 month ABBV is +6.3% and AZN +17.3%; over year to date ABBV is +28.6% and AZN +1.6%. The ABBV/AZN price ratio stands at 1.5736, below its 50-day average of 1.6344, and above the 200-day average of 1.3463. A ratio above its own average means ABBV is gaining on AZN; on this reading the recent edge belongs to AZN.
Compare ABBV and AZN: which has been stronger over the last year, and where does each stand against its 200-day average?Ask the analyst about this pair →
| ABBV | AZN | |
|---|---|---|
| Price | $293.89 | $186.76 |
| 1 day | +0.2%lead | -1.4% |
| 5 days | +2.8%lead | +1.6% |
| 1 month | +6.3% | +17.3%lead |
| 6 months | +45.8%lead | +2.1% |
| Year to date | +28.6%lead | +1.6% |
| 1 year | +34.4%lead | +6.7% |
| 2 years | +47.3% | — |
| 52-week position | 92% of range | 56% of range |
| 52-week range | $190.75–$302.93 | $153.41–$212.71 |
| vs 50-day average | above $273.45 | above $167.50 |
| vs 200-day average | above $239.68 | above $180.23 |
| RSI (14) | 62 | 66 |
| Market cap | $519.5B | — |
| Analyst target | $310.65 (+5.7%) | — |
| Analysts | 26 | — |
| Consensus | Buy | — |
| Next earnings | Oct 30, 2026 | Oct 30, 2026 |
ABBV trades at $293.89, above its 50-day average of $273.45, and above the 200-day at $239.68. It sits at 92% of its 52-week range ($190.75–$302.93); 14-day RSI is 62, in neutral territory; an average session moves it about 2.5%. For levels, the first level overhead is $294.89 (0.3% away) and the first support below is $275.00 (6.4% down). On the checklist the page runs for every asset, 5 of 6 checks read bullish — the lean is bullish.
AZN trades at $186.76, above its 50-day average of $167.50, and above the 200-day at $180.23. It sits at 56% of its 52-week range ($153.41–$212.71); 14-day RSI is 66, in neutral territory; an average session moves it about 2.7%. For levels, the first level overhead is $187.86 (0.6% away) and the first support below is $183.01 (2.0% down). On the checklist the page runs for every asset, 5 of 6 checks read bullish — the lean is bullish.
AZN is the more volatile of the two — an average session moves it 2.7% against 2.5% for ABBV, so an identical position size carries roughly 1.1× the daily risk.
The comparison turns on those levels: ABBV clearing $294.89 or losing $275.00; AZN clearing $187.86 or losing $183.01. Until one of them gives way, the relative reading above stands.